Nanalysis Scientific Corp.
OTC:NSCIF
0.3189 (USD) • At close November 15, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 11.474 | 11.162 | 9.8 | 7.036 | 6.956 | 4.674 | 7.203 | 6.878 | 5.187 | 5.554 | 5.089 | 3.336 | 4.343 | 3.277 | 2.655 | 1.7 | 1.995 | 1.523 | 2.123 | 1.641 | 2.535 | 2.065 | 2.786 | 1.797 | 2.179 | 1.619 |
| Cost of Revenue
| 9.344 | 9.893 | 9.133 | 5.41 | 5.672 | 4.342 | 5.568 | 3.906 | 1.955 | 2.209 | 2.001 | 1.224 | 1.421 | 1.155 | 0.852 | 0.644 | 0.731 | 0.541 | 0.407 | 0.384 | 0.768 | 0.73 | 0.884 | 0.611 | 0.749 | 0.73 |
| Gross Profit
| 2.13 | 1.269 | 0.667 | 1.626 | 1.284 | 0.332 | 1.635 | 2.972 | 3.232 | 3.345 | 3.088 | 2.112 | 2.922 | 2.122 | 1.803 | 1.056 | 1.264 | 0.982 | 1.716 | 1.257 | 1.767 | 1.335 | 1.902 | 1.186 | 1.429 | 0.889 |
| Gross Profit Ratio
| 0.186 | 0.114 | 0.068 | 0.231 | 0.185 | 0.071 | 0.227 | 0.432 | 0.623 | 0.602 | 0.607 | 0.633 | 0.673 | 0.648 | 0.679 | 0.621 | 0.634 | 0.645 | 0.808 | 0.766 | 0.697 | 0.646 | 0.683 | 0.66 | 0.656 | 0.549 |
| Reseach & Development Expenses
| 0.013 | 0.309 | -0.054 | 0.198 | 0.045 | 0.49 | 0.241 | 0.446 | 0.598 | 0.289 | 0.114 | 0.246 | 0.163 | 0.116 | 1.406 | 0 | 0 | 0 | 0.27 | 0 | 0 | 0 | 0.166 | 0 | 0 | 0 |
| General & Administrative Expenses
| 2.744 | 2.364 | 2.282 | 2.829 | 3.555 | 3.275 | 3.972 | 2.899 | 3.542 | 2.604 | 3.386 | 1.119 | 1.195 | 0.829 | 1.077 | 0.79 | 0.889 | 0.827 | 0.553 | 0.688 | 0.9 | 0.567 | 0.117 | 0.82 | 0.696 | 0.421 |
| Selling & Marketing Expenses
| 0.432 | 0.302 | 0.376 | 0.234 | 0.378 | 0.454 | 0.408 | 0.57 | 0.473 | 0.44 | -0.563 | 0.838 | 0.441 | 1.039 | 1.039 | 0.822 | 0.628 | 0.681 | 0.865 | 0.409 | 0.513 | 0.667 | 0.626 | 0.649 | 0.642 | 0.598 |
| SG&A
| 3.176 | 2.666 | 2.658 | 3.063 | 3.933 | 3.729 | 4.38 | 3.469 | 4.015 | 3.044 | 2.823 | 1.957 | 1.636 | 1.868 | 2.116 | 1.612 | 1.517 | 1.508 | 1.418 | 1.097 | 1.413 | 1.234 | 1.034 | 1.469 | 1.338 | 1.019 |
| Other Expenses
| 1.085 | 0 | -0.076 | 0 | 0 | 1.147 | 1.233 | 1.09 | 1.174 | 1.074 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.075 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 3.189 | 2.975 | 2.68 | 4.334 | 5.119 | 5.366 | 5.854 | 5.005 | 5.787 | 4.407 | 3.557 | 2.823 | 2.433 | 2.614 | 3.086 | 2.078 | 1.739 | 2.007 | 1.586 | 1.37 | 1.585 | 1.396 | 1.13 | 1.607 | 1.295 | 1.029 |
| Operating Income
| -1.059 | -1.706 | -2.013 | -2.964 | -3.44 | -5.004 | -4.32 | -1.742 | -2.562 | -1.062 | -0.12 | -0.717 | 0.5 | -0.277 | -1.049 | -0.864 | -0.338 | -0.961 | 1.631 | -0.039 | 0.211 | -0.061 | 0.811 | -0.391 | 0.091 | -0.131 |
| Operating Income Ratio
| -0.092 | -0.153 | -0.205 | -0.421 | -0.495 | -1.071 | -0.6 | -0.253 | -0.494 | -0.191 | -0.024 | -0.215 | 0.115 | -0.085 | -0.395 | -0.508 | -0.169 | -0.631 | 0.768 | -0.024 | 0.083 | -0.03 | 0.291 | -0.218 | 0.042 | -0.081 |
| Total Other Income Expenses Net
| -0.707 | -0.608 | 1.143 | -3.411 | -0.395 | 0.124 | 0.326 | -0.627 | -0.078 | -0.333 | -0.349 | 0.006 | -0.011 | -0.215 | -0.205 | -0.158 | -0.137 | -0.064 | 0.107 | -0.097 | -1.359 | -0.125 | -0.005 | -0.132 | -0.056 | -0.041 |
| Income Before Tax
| -1.766 | -2.314 | -0.87 | -6.408 | -4.366 | -4.88 | -3.994 | -2.369 | -2.64 | -1.395 | -0.9 | -0.826 | 0.445 | -0.467 | -1.246 | -1.183 | -0.607 | -1.003 | 0.316 | -0.298 | -1.213 | -0.201 | 0.806 | -0.523 | 0.035 | -0.172 |
| Income Before Tax Ratio
| -0.154 | -0.207 | -0.089 | -0.911 | -0.628 | -1.044 | -0.554 | -0.344 | -0.509 | -0.251 | -0.177 | -0.248 | 0.102 | -0.143 | -0.469 | -0.696 | -0.304 | -0.659 | 0.149 | -0.182 | -0.479 | -0.097 | 0.289 | -0.291 | 0.016 | -0.106 |
| Income Tax Expense
| -0.006 | 0.008 | 0.982 | -0.121 | -0.312 | -0.56 | -0.702 | 0.23 | -0.108 | 0.097 | -0.255 | 0.031 | 0.223 | -0.025 | -0.038 | -0.084 | -0.082 | -0.093 | 0.297 | 0.162 | -0.036 | 0.015 | 0.062 | 0 | 0 | 0 |
| Net Income
| -1.995 | -2.522 | -2.123 | -6.287 | -3.831 | -4.32 | -3.292 | -2.599 | -2.532 | -1.492 | -0.645 | -0.857 | 0.222 | -0.467 | -1.208 | -1.099 | -0.525 | -0.91 | 0.019 | -0.298 | -1.177 | -0.201 | 0.744 | -0.523 | 0.035 | -0.172 |
| Net Income Ratio
| -0.174 | -0.226 | -0.217 | -0.894 | -0.551 | -0.924 | -0.457 | -0.378 | -0.488 | -0.269 | -0.127 | -0.257 | 0.051 | -0.143 | -0.455 | -0.646 | -0.263 | -0.598 | 0.009 | -0.182 | -0.464 | -0.097 | 0.267 | -0.291 | 0.016 | -0.106 |
| EPS
| -0.018 | -0.024 | -0.021 | -0.062 | -0.039 | -0.046 | -0.035 | -0.028 | -0.027 | -0.017 | -0.008 | -0.012 | 0.003 | -0.007 | -0.02 | -0.017 | -0.008 | -0.014 | 0 | -0.005 | -0.023 | -0.003 | 0.016 | -0.012 | 0.001 | -0.002 |
| EPS Diluted
| -0.018 | -0.024 | -0.021 | -0.062 | -0.039 | -0.046 | -0.035 | -0.028 | -0.027 | -0.017 | -0.008 | -0.012 | 0.003 | -0.007 | -0.018 | -0.017 | -0.008 | -0.014 | -0.001 | -0.005 | -0.023 | -0.003 | 0.014 | -0.012 | 0.001 | -0.002 |
| EBITDA
| 0.095 | -0.554 | -0.938 | -1.831 | -2.224 | -3.778 | -3.06 | -0.64 | -1.366 | 0.029 | 0.512 | -0.081 | 1.155 | 0.367 | -0.584 | -0.332 | -0.078 | -0.448 | 1.811 | 0.254 | 0.402 | 0.121 | 0.86 | -0.263 | 0.207 | -0.026 |
| EBITDA Ratio
| 0.008 | -0.05 | -0.096 | -0.26 | -0.32 | -0.808 | -0.425 | -0.093 | -0.263 | 0.005 | 0.101 | -0.024 | 0.266 | 0.112 | -0.22 | -0.195 | -0.039 | -0.294 | 0.853 | 0.155 | 0.159 | 0.059 | 0.309 | -0.146 | 0.095 | -0.016 |